GlassScriptPhysician profile
William Bradley Roepke
NPI 1780262329
$3,756.05
in general payments reported to CMS, 2019-2025
12 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,229 · 2023: $166 · 2024: $611 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,054 · Travel and Lodging: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.55 |
| Travel and Lodging | $473.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,312.99 | 2022-2024 | |
| Stryker Corporation | $948.38 | 2022-2025 | Hoffmann, Mako, Na |
| Medacta USA, INC. | $524.01 | 2025 | Amistem, Reverse Shoulder |
| Acera Surgical, INC. | $257.82 | 2024-2025 | Restrata Wound Matrix |
| Kerecis Limited | $207.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lifenet Health | $145.47 | 2023 | |
| Medical Device Business Services, INC. | $141.84 | 2025 | Inhance |
| Axogen | $117.71 | 2025 | |
| P Bar Medical LLC | $43.52 | 2025 | |
| Organogenesis INC. | $28.99 | 2024 | Puraply Am |
| Kci USA, INC. | $20.55 | 2023 | Prevena, V.A.C.Ulta |
| Depuy Synthes Sales INC. | $7.60 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Roepke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.